GEDÜK, A. Et Al. 2015. The Role of beta-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.15, no.12 , 785-789.

GEDÜK, A., Atesoglu, E. B., TARKUN, P., MEHTAP, Ö., Hacihanefioglu, A., Demirsoy, E. T., ... BAYDEMİR, C.(2015). The Role of beta-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.15, no.12, 785-789.

GEDÜK, AYFER Et Al. "The Role of beta-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.15, no.12, 785-789, 2015

GEDÜK, AYFER Et Al. "The Role of beta-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.15, no.12, pp.785-789, 2015

GEDÜK, A. Et Al. (2015) . "The Role of beta-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.15, no.12, pp.785-789.

@article{article, author={AYFER GEDÜK Et Al. }, title={The Role of beta-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2015, pages={785-789} }